We are excited to welcome five new members to the Journal of Child Psychology and Psychiatry (JCPP) editorial board. With their wide-ranging expertise and many years of cultivated academic prowess, they are an immensely valuable addition to the team.
Professor Angelica Ronald is a Professor of Psychology and Genetics and Director of the Genes Environment Lifespan (GEL) laboratory within the Centre for Brain and Cognitive Development in the Department of Psychological Sciences at Birkbeck, University of London, UK.
Angelica’s research interests include: quantitative genetics; molecular genetics; child and adolescent psychopathology; autistic spectrum disorders; attention deficit hyperactivity disorder (ADHD); psychosis; co-occurrence of psychopathology; and genetic and environmental risk factors across development.
“I’ve been an admirer of the JCPP since my undergraduate days at Oxford at the end of the last millennium. So it blew my mind when, last summer, I was invited to take up such a prestigious role on the JCPP team. The journal is hugely indebted to the many wonderful scientists who have acted as JCPP editors up until now and I am extremely honoured to follow in their footsteps and take up this busy but ever-so-rewarding role. Edmund, the editorial team at ACAMH, and all my editor colleagues are an inspiration to work alongside.”
Professor Scott Kollins is a tenured Professor in the Department of Psychiatry and Behavioral Sciences at the Duke University School of Medicine, Durham, NC, USA. Scott is the Global Lead for ADHD and Substance Use Disorders at the Duke Clinical Research Institute (DCRI). He is also the Director of the Duke ADHD Program. Scott has published more than 140 scientific papers in peer-reviewed journals. Over the past 15 years, Scott’s research has been supported by 7 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, FDA, and EPA. In 2018, Scott received nearly $2 million in NIH funding for his work, ranking him among the Top 100 Psychiatry faculty members in the US. He currently holds a K24 career development award from NIDA.
Scott has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. Scott is an elected member of the College of Problems of Drug Dependence and is a Fellow of the American College of Neuropsychopharmacology and the American Psychological Association Division 28 (Psychopharmacology and Substance Abuse). He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He has previously served as Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. Scott is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. Scott’s research interests are in the areas of psychopharmacology; the intersection of ADHD and substance abuse; and applications of data science and digital health to child psychology and psychiatry.
“I am humbled by the opportunity to serve the field in my role as part of the JCPP team. In my role on the editorial board, I am thrilled by the chance to stay abreast of the most cutting-edge research, as well as to serve alongside such a distinguished team of colleagues.”
Specialist Subject Editor – Psychosis
Dr Helen Fisher is a Reader in Developmental Psychopathology, a Chartered Research Psychologist, and a British Academy Mid-Career Fellow within the Social, Genetic and Developmental Psychiatry Centre, at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK. She has a strong interdisciplinary background in psychology, social psychiatry, genetics, and epidemiology, funded through pre- and post-doctoral fellowships from the MRC and ESRC.
Helen has spent 18 years researching the aetiology and treatment of psychosis in young people. Her initial research involved evaluating Early Intervention Services for young people with psychosis, and then focused on the role of childhood maltreatment in the development and course of psychosis. During her MQ Fellows award she extended this work to explore the social, psychological and epigenetic factors that increase and decrease the risk of psychotic experiences developing and persisting during adolescence amongst victimised children. Currently, her research programme examines the role of the wider environment (neighbourhood social factors and air pollution) in the emergence of psychotic phenomena and other mental health problems during adolescence; epigenetic signatures of victimisation and psychosis; the phenomenology of childhood psychotic symptoms; predicting which victimised children will have poor functioning and develop psychopathology in late adolescence; improving public understanding of psychosis through immersive art experiences; and early identification of adolescents at risk for depression around the globe. She is also a co-investigator of the Environmental Risk (E-Risk) Longitudinal Twin Study and a Research Consultant for the NSPCC.
“It is an absolute honour to be joining the prestigious JCPP team as a specialist editor for psychosis. Psychotic phenomena are surprisingly common during childhood and adolescence and deserve greater research and clinical attention. I’m excited to have the opportunity to read and encourage submissions to JCPP on the aetiology, phenomenology, prevention, and treatment of psychosis during these key stages of development.”
Professor Joan Luby is the Samuel and Mae S. Ludwig Professor of Child Psychiatry and Director of the Early Emotional Development Program at the Washington University School of Medicine, St. Louis, MO, USA. She is also Co-PI of the NIMH Post-doctoral training program in developmental affective neuroscience. Joan’s research interests include: studies of early onset depression, validators, clinical characteristics, biological markers and alterations in brain structure and function related to early onset depression; psychotherapeutic treatments for early onset depression focusing on emotion development; studies of early experience and brain development; effects of poverty on brain development; investigation of the mechanisms of adversity and nurturance on neurodevelopment; and sensitive periods in emotion development.
“I look forward to joining the JCPP team and being a part of this distinguished and high-quality international journal. I see this as an opportunity to review and advance rigorous and innovative research on developmental psychopathology.”
Specialist Subject Editor – Molecular Genetics
Professor Barbara Franke holds the Chair of Molecular Psychiatry at Radboud University in Nijmegen, The Netherlands, where she is based at the Human Genetics and Psychiatry departments of the Radboud University Medical Center (Radboudumc). She is also a Principal Investigator at the Donders Institute for Brain, Cognition and Behaviour. At Radboudumc, she heads the Division of Genome Research and the Radboud Research Theme Neurodevelopmental Disorders. Since 2019, she also holds an honorary Adjunct Professorship at the Goethe University in Frankfurt am Main, Germany.
Barbara’s research is focused on understanding the genetic contribution to neurodevelopmental psychiatric disorders, especially ADHD and autism and their comorbidities. Beyond gene-finding, she uses complementary approaches (bioinformatics, i-neurons, small animal models, neuroimaging genetics) to map biological pathways from gene to disease.
Barbara is an elected member of the Royal Netherlands Academy of Arts and Sciences, the Royal Holland Society of Sciences and Humanities, and of Academia Europaea. She has coordinated EU-funded consortium grants and leads work packages in several additional ones. She founded and coordinates the International Multicentre persistent ADHD Collaboration (IMpACT) and the ECNP Network ‘ADHD across the Lifespan’. She is also a co-founder of ENIGMA, and is one of two leaders of ENIGMA’s ADHD Working Group and the Psychiatric Genomics Consortium’s ADHD Working Group. In 2018, she was elected to the Board of Directors of the International Society for Psychiatric Genetics. Barbara has also (co-)authored over 400 peer-reviewed publications and is on Clavirate’s list of the 1% most highly cited researchers.
“’I’m honored to have been invited to join the JCPP Editorial Board! Recent biological research in psychiatry teaches us about the dimensionality of the disorders we study and about the importance of a lifespan perspective in child and adolescent psychiatry. Seeing this view reflected in JCPP makes me look forward to being part of the team of editors.”